AZD8931 (Sapitinib)
Catalog No. A10116
AZD8931 (Sapitinib)是ErbB1,ErbB2和ErbB3受体信号传导的等效抑制剂。
- Takeshi Ito, .et al. Mathematical analysis of gefitinib resistance of lung adenocarcinoma caused by MET amplification, Biochem Biophys Res Commun, 2019, in Press
Catalog Num | A10116 |
---|---|
M. Wt | 473.9 |
Formula | C23H25ClFN5O3 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 848942-61-0 |
Synonyms | AZD-8931, Momelotinib, Sapitinib |
SMILES | CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC |
AZD8931 (Sapitinib)是ErbB1,ErbB2和ErbB3受体信号传导的等效抑制剂。
Targets
ErbB2 (Cell-free assay) | EGFR (Cell-free assay) | ErbB3 (Cell-free assay) | ||
3 nM | 4 nM | 4 nM |
In vitro (25°C) | DMSO | 37 mg/mL (78.07 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 30% PEG400+0.5% Tween80+5% propylene glycol | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.1 mL | 105.51 mL | 211.01 mL |
0.5 mM | 4.22 mL | 21.1 mL | 42.2 mL |
1 mM | 2.11 mL | 10.55 mL | 21.1 mL |
5 mM | 0.42 mL | 2.11 mL | 4.22 mL |
*The above data is based on the productmolecular weight 473.9 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.